Avita Medical | 1811094D - SCHULD

Aktienkurs
1.17
Täglich Wechseln
-0.02 -1.27%
Monatlich
-2.09%
Jährlich
-61.26%
Q1 Prognose
1.23




SCHULD Veränderung Datum
Accuray USD 170.24M 4.52M 2024-09
Celltrion KRW 171.09B 2.05T 2025-06
Clinuvel Pharmaceuticals AUD 879.78K 189.09K 2024-06
Cochlear AUD 235.7M 10.9M 2025-06
CSL USD 11.96B 219M 2024-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 106.24M 1.5M 2025-09
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Mayne Pharma AUD 38.82M 2.24M 2024-06
Medical Developments International AUD 1.99M 152K 2025-06
Nanosonics AUD 7.69M 1.49M 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Ovoca Bio EUR 0 0 2021-06
Pacific Edge NZD 2.9M 425K 2025-03
Paradigm Biopharmaceuticals AUD 181.4K 38.99K 2024-12
Pharma Mar EUR 49.42M 1.98M 2025-12
Polynovo AUD 15.38M 49K 2024-06
PYC Therapeutics AUD 1.02M 185.07K 2025-06
Qiagen NV USD 2.13B 683.16M 2025-09
Ramsay Health Care AUD 12.12B 864.4M 2025-06
ResMed USD 846.35M 5.46M 2025-09
Sartorius EUR 4.66B 25.7M 2025-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Telix Pharmaceuticals AUD 418.25M 163.2M 2025-06
Tilray USD 640.95M 35.17M 2022-06
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06